Heartflow, Inc.
56.71USD
+1.2800 (+2.31%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on HTFL.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | -$0.1▲ | -$0.11 | 0 | 0 |
| Next quarter | -$0.09▼ | -$0.09 | 0 | 0 |
| Current year | -$0.41▲ | -$0.49 | 0 | 0 |
| Next year | -$0.27▼ | -$0.26 | 0 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | -$0.13 | -$0.07 | +0.06 (+47.8%) |
| 2026-03-31 | -$0.17 | -$0.16 | +0.01 (+8.5%) |
| 2025-12-31 | -$0.16 | -$0.12 | +0.04 (+23.2%) |
| 2025-09-30 | -$0.24 | -$0.27 | -0.03 (-12.5%) |
27 ratings from 10 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Piper Sandler | Reiterated | Overweight | $45 $64 | Oct 20, 2026 |
| Canaccord Genuity | Maintained | Buy | $45 $56 | Sep 22, 2026 |
| UBS | Initiated | Neutral | $55 | Sep 9, 2026 |
| Canaccord Genuity | Maintained | Buy | $37 $45 | Aug 14, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $35 $40 | Aug 14, 2026 |
| Piper Sandler | Reiterated | Overweight | $38 $45 | Aug 14, 2026 |
| JP Morgan | Maintained | Overweight | $35 $45 | Aug 14, 2026 |
| Wells Fargo | Maintained | Overweight | $37 $39 | Aug 14, 2026 |
| Stifel | Maintained | Buy | $40 $45 | Aug 14, 2026 |
| Baird | Initiated | Outperform | $34 | Jul 31, 2026 |
| Freedom Capital Markets | Initiated | Buy | $37 | Jul 1, 2026 |
| Canaccord Genuity | Maintained | Buy | $43 $37 | May 15, 2026 |
| Wells Fargo | Maintained | Overweight | $35 $37 | May 15, 2026 |
| William Blair | Initiated | Outperform | — | May 4, 2026 |
| JP Morgan | Maintained | Overweight | $40 $35 | Mar 19, 2026 |
| Canaccord Genuity | Maintained | Buy | $40 $43 | Mar 19, 2026 |
| Wells Fargo | Maintained | Overweight | $38 $35 | Mar 19, 2026 |
| Canaccord Genuity | Maintained | Buy | $40 | Mar 9, 2026 |
| Wells Fargo | Initiated | Overweight | $38 | Jan 28, 2026 |
| Canaccord Genuity | Maintained | Buy | $39 $40 | Nov 13, 2025 |
| JP Morgan | Maintained | Overweight | $36 $40 | Nov 13, 2025 |
| Stifel | Maintained | Buy | $35 $40 | Nov 13, 2025 |
| Canaccord Genuity | Maintained | Buy | $35 $39 | Sep 22, 2025 |
| Stifel | Initiated | Buy | $35 | Sep 2, 2025 |
| Canaccord Genuity | Initiated | Buy | $35 | Sep 2, 2025 |
74 filings from 14 insiders · 14 buy / 18 sell over 6m
Officers and directors of HTFL, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Farquhar John C.M.Director; Officer, Chief Executive Officer | Sell | 38.9k | $49.57 | $1.93M | Oct 12, 2026 |
| Rogers CampbellOfficer, Chief Medical Officer | ExerciseStock Option | 850 | — | — | Sep 18, 2026 |
| Rogers CampbellOfficer, Chief Medical Officer | ExerciseStock Option | 12.3k | — | — | Sep 18, 2026 |
| Rogers CampbellOfficer, Chief Medical Officer | Sell | 19.7k | $50.15 | $987k | Sep 18, 2026 |
| Rogers CampbellOfficer, Chief Medical Officer | Exercise | 850 | $2.22 | $2k | Sep 18, 2026 |
| Rogers CampbellOfficer, Chief Medical Officer | Exercise | 12.3k | $8.33 | $103k | Sep 18, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 16.8k | $50.75 | $851k | Sep 18, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 7.6k | $50.11 | $380k | Sep 17, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 668 | $50.01 | $33k | Sep 15, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 4.6k | $50.24 | $231k | Sep 14, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 29.7k | $50.06 | $1.49M | Sep 11, 2026 |
| Farquhar John C.M.Director; Officer, Chief Executive Officer | Sell | 3.9k | $50.00 | $195k | Sep 11, 2026 |
| Farquhar John C.M.Director; Officer, Chief Executive Officer | Sell | 35.0k | $46.42 | $1.63M | Sep 10, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 6.6k | $50.03 | $332k | Sep 8, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 27.5k | $49.69 | $1.37M | Sep 3, 2026 |
| Verghese VikramOfficer, Chief Financial Officer | Sell | 5.9k | $50.60 | $297k | Sep 2, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Sell | 27.2k | $50.00 | $1.36M | Aug 21, 2026 |
| FARQUHAR JOHN C. M.Chief Executive Officer | Sell | 32.7k | $45.00 | $1.47M | Aug 18, 2026 |
| ROGERS CAMPBELL M.D.Officer | Sell | 9.2k | $41.23 | $380k | Aug 17, 2026 |
| ROGERS CAMPBELL M.D.Officer | Exercise | 9.2k | $19.00 | $175k | Aug 17, 2026 |
No analyst notes on HTFL yet.
Analyst Ratings
8 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 6 | 1 | 0 | 0 | Buy1.89 |
| 1 mo ago | 2 | 6 | 2 | 0 | 0 | Buy2.00 |
| 2 mo ago | 2 | 6 | 1 | 0 | 0 | Buy1.89 |
| 3 mo ago | 2 | 6 | 1 | 0 | 0 | Buy1.89 |
Members whose judged calls on HTFL have played out most reliably.
No settled calls on HTFL yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice